These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29941155)

  • 1. The Unmet Promise of a Miracle Drug for Alzheimer's Disease: Implications for Practice, Policy, and Research.
    Sloane PD; Zimmerman S; Boustani M
    J Am Med Dir Assoc; 2018 Jul; 19(7):557-559. PubMed ID: 29941155
    [No Abstract]   [Full Text] [Related]  

  • 2. As drug trials fail, Alzheimer's researchers look toward prevention.
    Rice S
    Mod Healthc; 2014 Jan; 44(4):8-9. PubMed ID: 24640402
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease: overview of research and clinical advances.
    Libow LS
    Manag Care Interface; 2007 Mar; 20(3):20-3. PubMed ID: 17458476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on "Design of comprehensive Alzheimer's disease centers to address unmet national needs".
    Sabbagh MN
    Alzheimers Dement; 2010 Mar; 6(2):156-7. PubMed ID: 20298980
    [No Abstract]   [Full Text] [Related]  

  • 5. Disease-modifying trials in Alzheimer's disease: a European task force consensus.
    Vellas B; Andrieu S; Sampaio C; Wilcock G;
    Lancet Neurol; 2007 Jan; 6(1):56-62. PubMed ID: 17166802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
    Gauthier S; Poirier J
    Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
    [No Abstract]   [Full Text] [Related]  

  • 7. The Alzheimer's Disease Cooperative Study in 2004.
    Thal LJ
    Alzheimer Dis Assoc Disord; 2004; 18(4):183-5. PubMed ID: 15592126
    [No Abstract]   [Full Text] [Related]  

  • 8. The Alzheimer's Study Group's recommendations five years later: planning has advanced, but agenda remains unfinished.
    Egge R
    Health Aff (Millwood); 2014 Apr; 33(4):555-60. PubMed ID: 24711314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Setbacks in Alzheimer research demand new strategies, not surrender.
    Jobke B; McBride T; Nevin L; Peiperl L; Ross A; Stone C; Turner R;
    PLoS Med; 2018 Feb; 15(2):e1002518. PubMed ID: 29486005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model.
    Bateman RJ; Benzinger TL; Berry S; Clifford DB; Duggan C; Fagan AM; Fanning K; Farlow MR; Hassenstab J; McDade EM; Mills S; Paumier K; Quintana M; Salloway SP; Santacruz A; Schneider LS; Wang G; Xiong C;
    Alzheimers Dement; 2017 Jan; 13(1):8-19. PubMed ID: 27583651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latest Alzheimer's research: some rays of hope.
    Johns Hopkins Med Lett Health After 50; 2012 May; 24(3):1-2. PubMed ID: 22649822
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.
    Fillit H; Nash DT; Shineman D
    Alzheimers Dement; 2009 Mar; 5(2):149-53. PubMed ID: 19328448
    [No Abstract]   [Full Text] [Related]  

  • 13. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2020 Mar; 15(3):269-271. PubMed ID: 31592694
    [No Abstract]   [Full Text] [Related]  

  • 14. Nanotherapeutic strategies for the treatment of Alzheimer's disease.
    Gu X; Chen H; Gao X
    Ther Deliv; 2015 Feb; 6(2):177-95. PubMed ID: 25690086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 14th International Conference on Alzheimer's Drug Discovery, 9 - 10 September 2013, in Jersey City, New Jersey.
    Glicksman MA
    Expert Opin Drug Discov; 2014 Feb; 9(2):215-20. PubMed ID: 24444088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for designating Alzheimer's disease research a national priority.
    Khachaturian ZS
    Alzheimers Dement; 2011 Nov; 7(6):557-61. PubMed ID: 22055971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
    Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
    NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease takes federal spotlight.
    Traynor K
    Am J Health Syst Pharm; 2012 Jul; 69(13):1101-2. PubMed ID: 22722584
    [No Abstract]   [Full Text] [Related]  

  • 20. New approaches to Alzheimer's disease.
    Beresford L
    Healthplan; 1997; 38(1):77-8, 80-1. PubMed ID: 10172939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.